Literature DB >> 1483700

Alport syndrome: a genetic study of 31 families.

R M'Rad1, M Sanak, G Deschenes, J Zhou, C Bonaiti-Pellie, L Holvoet-Vermaut, S Heuertz, M C Gubler, M Broyer, J P Grunfeld.   

Abstract

Thirty one families with Alport syndrome including 3 families with associated syndromes were studied. The location of the COL4A5 gene, responsible for the Alport syndrome, was determined by linkage analysis with eight probes of the Xq arm and by a radiation hybrid panel. Concordant data indicated the localization of the Alport gene between DXS17 and DXS11. Four deletions and one single base mutation of the COL4A5 gene were detected. Homogeneity tests failed to show any evidence of genetic heterogeneity superimposed on clinical heterogeneity for ophthalmic signs and end-stage renal disease age.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1483700     DOI: 10.1007/bf00220471

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  40 in total

1.  The detection and estimation of linkage between the genes for elliptocytosis and the Rh blood type.

Authors:  N E MORTON
Journal:  Am J Hum Genet       Date:  1956-06       Impact factor: 11.025

2.  Report of the Committee on Methods of Linkage Analysis and Reporting.

Authors:  P M Conneally; J H Edwards; K K Kidd; J M Lalouel; N E Morton; J Ott; R White
Journal:  Cytogenet Cell Genet       Date:  1985

3.  X-linked hypohidrotic ectodermal dysplasia: DNA probe linkage analysis and gene localization.

Authors:  A Clarke; M Sarfarazi; N S Thomas; K Roberts; P S Harper
Journal:  Hum Genet       Date:  1987-04       Impact factor: 4.132

4.  Identification of a distinct type IV collagen alpha chain with restricted kidney distribution and assignment of its gene to the locus of X chromosome-linked Alport syndrome.

Authors:  S L Hostikka; R L Eddy; M G Byers; M Höyhtyä; T B Shows; K Tryggvason
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

5.  A strategy to reveal high-frequency RFLPs along the human X chromosome.

Authors:  J Aldridge; L Kunkel; G Bruns; U Tantravahi; M Lalande; T Brewster; E Moreau; M Wilson; W Bromley; T Roderick
Journal:  Am J Hum Genet       Date:  1984-05       Impact factor: 11.025

6.  Alport's syndrome: experience at Hôpital Necker.

Authors:  R Habib; M C Gubler; N Hinglais; L H Noël; D Droz; M Levy; P Mahieu; J M Foidart; D Perrin; E Bois; J P Grünfeld
Journal:  Kidney Int Suppl       Date:  1982-05       Impact factor: 10.545

7.  Hereditary nephritis with associated defects in proximal renal tubular function.

Authors:  J H Passwell; R David; H Boichis; S Herzfeld
Journal:  J Pediatr       Date:  1981-01       Impact factor: 4.406

8.  Major rearrangements in the alpha 5(IV) collagen gene in three patients with Alport syndrome.

Authors:  E Boye; D Vetrie; F Flinter; B Buckle; T Pihlajaniemi; E R Hamalainen; J C Myers; M Bobrow; A Harris
Journal:  Genomics       Date:  1991-12       Impact factor: 5.736

9.  Strategies for multilocus linkage analysis in humans.

Authors:  G M Lathrop; J M Lalouel; C Julier; J Ott
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

10.  Alport syndrome and diffuse leiomyomatosis: deletions in the 5' end of the COL4A5 collagen gene.

Authors:  C Antignac; J Zhou; M Sanak; P Cochat; B Roussel; G Deschênes; F Gros; B Knebelmann; M C Hors-Cayla; K Tryggvason
Journal:  Kidney Int       Date:  1992-11       Impact factor: 10.612

View more
  2 in total

1.  Genetic homogeneity of Pelizaeus-Merzbacher disease: tight linkage to the proteolipoprotein locus in 16 affected families. PMD Clinical Group.

Authors:  O Boespflug-Tanguy; C Mimault; J Melki; A Cavagna; G Giraud; D Pham Dinh; B Dastugue; A Dautigny
Journal:  Am J Hum Genet       Date:  1994-09       Impact factor: 11.025

2.  Deletions in the COL4A5 collagen gene in X-linked Alport syndrome. Characterization of the pathological transcripts in nonrenal cells and correlation with disease expression.

Authors:  C Antignac; B Knebelmann; L Drouot; F Gros; G Deschênes; M C Hors-Cayla; J Zhou; K Tryggvason; J P Grünfeld; M Broyer
Journal:  J Clin Invest       Date:  1994-03       Impact factor: 14.808

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.